Patents by Inventor Yoshio Furutani

Yoshio Furutani has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5612192
    Abstract: A neutral protease gene of Bacillus amyloliquefaciens is cloned, which gene comprises the promoter region, the ribosome binding region, the region involved in the secretion of the neutral protease, the region consisting of the structural gene for the neutral protease, and the terminator region. Each of the regions is useful as a material for construction of a recombinant DNA used for the production of proteins by culturing a host bacterium transformed with the recombinant DNA. For example, the extracellular production of neutral protease in a large amount can be accomplished by culturing B. subtilis transformed with a recombinant DNA comprising pUB110 and the neutral protease gene.
    Type: Grant
    Filed: December 20, 1994
    Date of Patent: March 18, 1997
    Assignees: Agency of Industrial Science and Technology, Extra-Ministerial Bureau of Ministry of International Trade and Industry
    Inventors: Yoshio Furutani, Hiroaki Shimada, Izumi Mita, Kazuaki Manabe, Masaru Honjo, Noboru Tomioka
  • Patent number: 5166318
    Abstract: Modified HV1-type hirudinin which valine at the N-terminal end of the HV1-type hirudin and aspartic acid at the 5th residue of the N-terminal end were replaced with alanine and glutamic acid, respectively. A secretion plasmid into which a DNA sequence coding for a precursor with an addition of a secretion signal of neutral protease of Bacillus amyloliquefaciens at the N-terminal end of this modified HV1-type hirudin is integrated is introduced into bacteria of the genus Bacillus and the precursor is expressed intracellularly. The modified HV1-type hirudin can be efficiently secreted extracellularly while maintaining its high thrombin inhibiting activity.
    Type: Grant
    Filed: June 4, 1990
    Date of Patent: November 24, 1992
    Assignee: Mitsui Toatsu Chemicals, Incorporated
    Inventors: Yoshio Furutani, Masaru Honjo, Akira Nakayama, Koichi Kawamura, Kazunori Ando, Michiko Hori, Keiko Fukazawa
  • Patent number: 5084383
    Abstract: Residual extracellular protease activities of a Bacillus subtilis strain can be further reduced by introducing a gene for the stimulation of extracellular protease levels into the genomic DNA of the strain.The resultant strain whose extracellular protease activities are further reduced is transformed with a recombinant plasmid for secretion of a desired protein and the desired protein can be efficiently produced and accumulated in the culture medium in a large amount. The accumulated desired protein can be easily recovered from the culture medium.For example, the accumulation level of human growth hormone secreted by a B. subtilis MT-430 strain carrying recombinant DNA phGH427 for the expression and secretion of human growth hormone can be increased five to tenfold as a result of the above treatment for reduction of the residual extracellular protease activities of the extracellular protease-activity-deficient strain.
    Type: Grant
    Filed: July 18, 1990
    Date of Patent: January 28, 1992
    Assignees: Agency of Industrial Science and Technology, Ministry of International Trade and Industry
    Inventors: Yoshio Furutani, Masaru Honjo, Akira Nakayama, Koichi Kawamura, Hiroaki Shimada, Izumi Mita, Akiko Akaoka
  • Patent number: 5015574
    Abstract: A expression-secretion vector is constructed by using a DNA sequence comprising a DNA fragment obtained by subjecting a DNA sequence consisting of a region involved in the expression of a gene coding for an extracellular enzyme of a bacterium of the genus Bacillus and a region involved in the secretion of the enzyme thus expressed to a deletion in the region involved in the secretion which can enhance the extracellular production of a protein dependent on the DNA fragment. By transforming a host bacterium with a recombinant DNA molecule formed by inserting a DNA fragment comprising a gene coding for a desired protein into the expression-secretion vector and then culturing the transformed host, the extracellular production of the desired protein in a large amount can be accomplished.
    Type: Grant
    Filed: November 20, 1986
    Date of Patent: May 14, 1991
    Assignees: Agency of Industrial Science and Technology, Extra-Ministerial Bureau of Ministry of International Trade and Industry
    Inventors: Yoshio Furutani, Akira Nakayama, Masaru Honjo, Hiroaki Shimada, Kouichi Kawamura, Izumi Mita, Akiko Akaoka
  • Patent number: 4824782
    Abstract: This invention relates to a DNA base sequence, capable of increasing the amount of protein secreted by microorganisms, and its derivative sequences; a recombinant plasmid including the whole or a part of said DNA base sequence; a method for preparing the recombinant plasmid in which, when microorganisms having introduced thereinto a recombinant DNA including the desired DNA base sequence are to be separated in the process of cloning, suitable transformants can be efficiently selected by taking the amount of protein secreted out of the cells and particularly the activity of an enzyme protein as an index; and a method of microbial breeding which comprises introducing the recombinant plasmid into a microorganism to increase the amount of protein secreted by the microorganism.
    Type: Grant
    Filed: April 8, 1988
    Date of Patent: April 25, 1989
    Assignees: Agency of Industrial Science and Technology, Ministry of International Trade and Industry
    Inventors: Yoshio Furutani, Noboru Tomioka, Masaru Honjo, Kazuaki Manabe, Hiroaki Shimada
  • Patent number: 4731327
    Abstract: A recombinant DNA molecule, a portion of which includes a vector whose replication is initiated independently of the temperature-sensitive mutant gene of a temperature-sensitive mutant strain of the genus Bacillus as host is introduced into the host. The host is then cultured at a temperature which does not completely inhibit chromosomal DNA replication. By this process, the recombinant DNA molecule can be stabilized in the host and its expression can be enhanced.
    Type: Grant
    Filed: August 18, 1986
    Date of Patent: March 15, 1988
    Assignees: Agency of Industrial Science and Technology, Ministry of International Trade and Industry
    Inventors: Yoshio Furutani, Masaru Honjo, Kazuaki Manabe, Hiroaki Shimada, Noboru Tomioka
  • Patent number: 4726947
    Abstract: Cells of a microorganism, such as Mycobacterium tuberculosis, belonging to the genus Mycobacterium are disrupted in distilled water or a suitable buffer solution, and then centrifuged or filtrated to remove the cell wall residue. To the aqueous cell-free extract is added a polyvalent metal salt or an antibiotic, such as streptomycin sulfate, which acts as a flocculant to form a precipitate. The precipitate consists essentially of sugar, protein, lipid, and nucleic acid. Owing to its high antitumor and adjuvant activities as well as its slight side effects, it can be used as antitumor and adjuvant preparations.
    Type: Grant
    Filed: June 8, 1981
    Date of Patent: February 23, 1988
    Assignee: Matsui Toatsu Chemicals, Inc.
    Inventors: Shizuo Shimada, Tadashi Sudo, Hitoshi Inoue, Yoshio Furutani, Yoshikazu Fujisawa
  • Patent number: 4579941
    Abstract: Thermally-denatured DNA MD-011 having an antitumor activity was obtained by heating the substance separated from the disrupted cells of bacteria belonging to genus Mycobacterium.
    Type: Grant
    Filed: August 13, 1982
    Date of Patent: April 1, 1986
    Assignee: Mitsuitoatsu Chemicals, Inc.
    Inventors: Yoshio Furutani, Hiroshi Yamamoto, Tamotsu Fukuda, Shizuo Shimada, Osamu Yano